GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BUE:ABT) » Definitions » Cyclically Adjusted PS Ratio

Abbott Laboratories (BUE:ABT) Cyclically Adjusted PS Ratio : 5.39 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Abbott Laboratories's current share price is ARS32072.00. Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ARS5,949.68. Abbott Laboratories's Cyclically Adjusted PS Ratio for today is 5.39.

The historical rank and industry rank for Abbott Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

BUE:ABT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.9   Med: 4.16   Max: 8.42
Current: 4.71

During the past years, Abbott Laboratories's highest Cyclically Adjusted PS Ratio was 8.42. The lowest was 1.90. And the median was 4.16.

BUE:ABT's Cyclically Adjusted PS Ratio is ranked worse than
69.81% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs BUE:ABT: 4.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was ARS9,595.817. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ARS5,949.68 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted PS Ratio Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.23 6.80 7.82 5.46 5.15

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 5.21 4.55 5.15 5.19

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PS Ratio falls into.



Abbott Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Abbott Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=32072.00/5949.68
=5.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9595.817/131.7762*131.7762
=9,595.817

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 54.169 100.560 70.985
201409 56.271 100.428 73.836
201412 60.179 99.070 80.046
201503 56.996 99.621 75.393
201506 62.461 100.684 81.750
201509 64.341 100.392 84.455
201512 89.736 99.792 118.497
201603 96.167 100.470 126.132
201606 100.715 101.688 130.515
201609 107.140 101.861 138.606
201612 113.940 101.863 147.400
201703 112.571 102.862 144.214
201706 125.144 103.349 159.566
201709 136.439 104.136 172.654
201712 164.910 104.011 208.932
201803 168.700 105.290 211.138
201806 219.010 106.317 271.456
201809 318.041 106.507 393.499
201812 330.102 105.998 410.382
201903 331.586 107.251 407.412
201906 400.236 108.070 488.034
201909 506.296 108.329 615.879
201912 557.880 108.420 678.060
202003 538.642 108.902 651.783
202006 562.088 108.767 680.993
202009 735.235 109.815 882.271
202012 972.818 109.897 1,166.497
202103 1,051.492 111.754 1,239.876
202106 1,080.060 114.631 1,241.599
202109 1,194.567 115.734 1,360.146
202112 1,299.711 117.630 1,456.021
202203 1,439.459 121.301 1,563.766
202206 1,534.503 125.017 1,617.470
202209 1,640.310 125.227 1,726.103
202212 1,930.722 125.222 2,031.780
202303 2,198.438 127.348 2,274.887
202306 2,736.435 128.729 2,801.217
202309 4,060.588 129.860 4,120.521
202312 4,235.362 129.419 4,312.490
202403 9,595.817 131.776 9,595.817

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott Laboratories  (BUE:ABT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Abbott Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (BUE:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (BUE:ABT) Headlines

From GuruFocus

Q4 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024